N3Y-25819-35374
2 vaccinations
5 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 442 / OH
- Registered
- 2022-09-17
- Relationship
- Child or adolescent in my care
- Guardian
- A6F-11920-44058
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-14
Dose 1 — Pfizer-BioNTechCo-administered: Flu:Hepatitis B:Hib:Pneumonia:Polio:Tetanus
-
2022-09-17
Registered in v-safe
- 2022-09-17
- 2022-09-19
- 2022-09-20
- 2022-09-21
-
2022-09-28
Survey response — day 14, dose 1, under 3MedDRA: Insomnia, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Running nose, congestion, trouble sleepingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-05
- 2022-10-12
-
2022-10-19
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
-
2022-10-23
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Insomnia — Feeling: GoodFree text: Didnt sleep much during napsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Fatigue — Feeling: GoodFree text: Not napping great todayMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Unevaluable event — Feeling: GoodFree text: Skipped first nap of the dayMedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2023-01-18
-
2023-04-21
Survey response — 6 months, dose 2, under 3MedDRA: Back pain, Office visit, Vulval disorder — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-04-21
Report sent to call center — 6 months, dose 2, under 3Get care from a doctor or other healthcare professional1 call case(s)
- 2023-04-25
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-14 | Pfizer-BioNTech | Flu:Hepatitis B:Hib:Pneumonia:Polio:Tetanus |
| 2 | 2022-10-19 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Running nose, congestion, trouble sleeping
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Didnt sleep much during naps
Systemic reaction (other): Not napping great today
Systemic reaction (other): Skipped first nap of the day
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vulval disorder | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release